Evidence map›Paper›PMID 26538417›Full record

ArticleEMBO reports2015

Myc coordinates transcription and translation to enhance transformation and suppress invasiveness.

Ran Elkon, Fabricio Loayza-Puch, Gozde Korkmaz, Rui Lopes, Pieter C van Breugel, Onno B Bleijerveld, A F Maarten Altelaar, Elmar Wolf, Francesca Lorenzin, Martin Eilers and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Ran ElkonDivision of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands r.agami@nki.nl r.elkon@nki.nl.
Fabricio Loayza-PuchDivision of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Gozde KorkmazDivision of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Rui LopesDivision of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pieter C van BreugelDivision of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Onno B BleijerveldMass Spectrometry/Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
A F Maarten AltelaarMass Spectrometry/Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences Utrecht University, Utrecht, The Netherlands Netherlands Proteomics Centre Cancer Genomics Centre, Utrecht, The Netherlands.
Elmar WolfBiozentrum der Universität Würzburg Theodor Boveri Institut Am Hubland, Würzburg, Germany.
Francesca LorenzinBiozentrum der Universität Würzburg Theodor Boveri Institut Am Hubland, Würzburg, Germany.
Martin EilersBiozentrum der Universität Würzburg Theodor Boveri Institut Am Hubland, Würzburg, Germany.
Reuven AgamiDivision of Biological Stress Response, The Netherlands Cancer Institute, Amsterdam, The Netherlands Erasmus MC, Rotterdam University, Rotterdam, The Netherlands r.agami@nki.nl r.elkon@nki.nl.
The Netherlands Cancer Institute · NLUniversity of Würzburg · DEErasmus University Rotterdam · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

c-Myc is one of the major human proto-oncogenes and is often associated with tumor aggression and poor clinical outcome. Paradoxically, Myc was also reported as a suppressor of cell motility, invasiveness, and metastasis. Among the direct targets of Myc are many components of the protein synthesis machinery whose induction results in an overall increase in protein synthesis that empowers tumor cell growth. At present, it is largely unknown whether beyond the global enhancement of protein synthesis, Myc activation results in translation modulation of specific genes. Here, we measured Myc-induced global changes in gene expression at the transcription, translation, and protein levels and uncovered extensive transcript-specific regulation of protein translation. Particularly, we detected a broad coordination between regulation of transcription and translation upon modulation of Myc activity and showed the connection of these responses to mTOR signaling to enhance oncogenic transformation and to the TGFβ pathway to modulate cell migration and invasiveness. Our results elucidate novel facets of Myc-induced cellular responses and provide a more comprehensive view of the consequences of its activation in cancer cells.

Indexed as

Gene Expression Regulation, NeoplasticNeoplasm InvasivenessApoptosisCell Line, TumorCell MovementCell ProliferationCell Transformation, NeoplasticGene Expression ProfilingGenes, mycHumansNeoplasm MetastasisNeoplasmsProtein BiosynthesisProto-Oncogene Proteins c-mycSignal TransductionTOR Serine-Threonine KinasesMTOR protein, humanMYC protein, humanProto-Oncogene Proteins c-mycTOR Serine-Threonine Kinasesc‐Mycmetastasistranscriptional responsestransformationtranslational regulation

Identifiers

PMID26538417
PMCPMC4687422
OpenAlexW1920458132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.